Home > Antonio Ceriello: A New Era in Diabetes Care
Diabetes

Antonio Ceriello: A New Era in Diabetes Care

Published Online: July 3rd 2020

touchENDOCRINOLOGY caught up with Dr Antonio Ceriello to discuss the European Steering Committee’s ‘A New Era in Diabetes Care’ report and what this means for patients with type 2 diabetes, chronic kidney disease and cardiovascular disease. For further information, please click here for the full report.

Questions

1. Please provide a brief overview of the aims of the European Steering Committee’s ‘A New Era in Diabetes Care’ report (0:06)

2. What differences exist in treatment guidelines across Europe and how can these be harmonised? (1:10)

3. What were the committee’s recommendations in terms of reviewing key performance indicators and treatment outcomes? (2:14)

4. What will be the next steps in developing a structured care plan for patients with type 2 diabetes, chronic kidney disease and cardiovascular disease? (3:27)

 

Speaker disclosure: Antonio Ceriello is on the advisory board for Abbott, BD, Eli Lilly, Mundipharma and Novo Nordisk. He has given lectures for Astra Zeneca, Berlin Chemie, Boehringer Ingelheim, Eli Lilly, Mundipharma, Novo Nordisk and Roche Diagnostics, and received research grants from Mitsubishi.

Support: Interview commissioned and filming supported by Touch Medical Media. Commissioned in liaison with Havas SO.

Published online: 3 July 2020

Related Videos In Diabetes
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar